Evidence map›Paper›PMID 39706851›Full record

ArticleSchizophrenia (Heidelberg, Germany)2024

Investigation of choroid plexus variability in schizophrenia-spectrum disorders-insights from a multimodal study.

Vladislav Yakimov, Joanna Moussiopoulou, Lukas Roell, Marcel S Kallweit, Emanuel Boudriot, Matin Mortazavi, Sergi Papiol, Lenka Krčmář, Mattia Campana, Eva C Schulte and 13 more

Abstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Vladislav YakimovDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany. V.Yakimov@med.uni-muenchen.de.ORCID http://orcid.org/0000-0001-9559-7492
Joanna MoussiopoulouDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Lukas RoellDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Marcel S KallweitDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Emanuel BoudriotDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-6083-6318
Matin MortazaviDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Sergi PapiolMax Planck Institute of Psychiatry, 80804, Munich, Germany.
Lenka KrčmářDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Mattia CampanaDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-4596-4287
Eva C SchulteInstitute of Psychiatric Phenomics and Genomics, LMU University Hospital, LMU Munich, Munich, Germany.
Nicolas GlaichenhausInstitut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur, Centre National de La Recherche Scientifique, Valbonne, France.
Emanuela MartinuzziInstitut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur, Centre National de La Recherche Scientifique, Valbonne, France.
Sean HalsteadMedical School, The University of Queensland, Brisbane, QLD, Australia.
Nicola WarrenMedical School, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0002-0805-1182
Dan SiskindMedical School, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0002-2072-9216
Isabel MaurusDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-6208-5180
Alkomiet HasanDZPG (German Center for Mental Health), partner site Munich/Augsburg, Munich, Germany.
Peter FalkaiDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-0284-2290
Andrea SchmittDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-5426-4023
Florian J RaabeDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
CDP Working Group
Daniel Keeser *Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-0244-1024
Elias Wagner *Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01EE2303ABundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01EE2303FBundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01EW2206Deutsche Forschungsgemeinschaft (German Research Foundation) INST 86/1739-1 FUGG
6 · The paper itself

Abstract

Previous studies have suggested that choroid plexus (ChP) enlargement occurs in individuals with schizophrenia-spectrum disorders (SSD) and is associated with peripheral inflammation. However, it is unclear whether such an enlargement delineates a biologically defined subgroup of SSD. Moreover, it remains elusive how ChP is linked to brain regions associated with peripheral inflammation in SSD. A cross-sectional cohort of 132 individuals with SSD and 107 age-matched healthy controls (HC) underwent cerebral magnetic resonance imaging (MRI) and clinical phenotyping to investigate the ChP and associated regions. A case-control comparison of ChP volumes was conducted, and structural variance was analyzed by employing the variability ratio (VR). K-means clustering analysis was used to identify subgroups with distinct patterns of the ventricular system, and the clusters were compared in terms of demographic, clinical, and immunological measures. The relationship between ChP volumes and brain regions, previously associated with peripheral inflammation, was investigated. We did not find a significant enlargement of the ChP in SSD compared to HC but detected an increased VR of ChP and lateral ventricle volumes. Based on these regions, we identified 3 clusters with differences in cognitive measures and possibly inflammatory markers. Larger ChP volume was associated with higher volumes of hippocampus, putamen, and thalamus in SSD but not in HC. This study suggests that ChP variability, but not mean volume, is increased in individuals with SSD, compared to HC. Larger ChP volumes in SSD were associated with higher volumes of regions previously associated with peripheral inflammation.

Identifiers

PMID39706851
PMCPMC11662021

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.